MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on every 2026 Arkansas Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Arkansas cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

Multiple sclerosis drugs by 2026 Arkansas Part D plan
DrugWellcare Classic$0.00/moS4802-073Wellcare Value Script$0.00/moS4802-153HealthSpring Assurance Rx$0.00/moS5617-225Humana Basic Rx Plan$0.00/moS5884-141Humana Value Rx Plan$0.00/moS5884-198BlueMedicare Value Rx$52.50/moS5795-003HealthSpring Extra Rx$54.50/moS5617-369AARP Medicare Rx Saver from UHC$65.10/moS5921-364SilverScript Choice$73.50/moS5601-038Humana Premier Rx Plan$92.40/moS5884-165AARP Medicare Rx Preferred from UHC$114.90/moS5921-400BlueMedicare Premier Rx$181.20/moS5795-002
KesimptaofatumumabNot coveredNot coveredTier 5PA25%QL 1.6/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA33%QL 6.4/365d
teriflunomidegeneric AubagioTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 4PA34%QL 30/30dTier 4PA33%QL 30/30dNot coveredNot coveredNot coveredTier 5PA25%QL 30/30dTier 4PA50%QL 30/30dTier 429%QL 30/30dNot covered
dimethyl fumarategeneric TecfideraTier 4PA26%QL 56/28dTier 4PA40%QL 56/28dTier 4PA29%QL 14/30dNot coveredNot coveredNot coveredTier 4PA31%QL 14/30dTier 432%QL 56/28dNot coveredTier 4PA50%QL 14/30dTier 429%QL 56/28dNot covered
Vumeritydiroximel fumarateNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
fingolimodgeneric GilenyaTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dNot coveredTier 3PA25%QL 30/30dTier 3PA20%QL 30/30dTier 5PA25%QL 30/30dNot coveredTier 432%QL 30/30dTier 5PA25%QL 30/30dTier 3PA$45.00QL 30/30dTier 429%QL 30/30dTier 5PA33%QL 30/30d
MayzentsiponimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ZeposiaozanimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
MavencladcladribineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.